Objectives: Primary cervical screening uses cytology to detect cancer precursor lesions
[cervical intraepithelial neoplasia stage 3 or beyond (CIN3+)]. Human papillomavirus (HPV) …

Objectives: To compare the sensitivity, specificity, and interobserver reliability of
conventional cervical smear tests, monolayer cytology, and human papillomavirus testing for …

Objectives Cervical screening strives to prevent cervical cancer (CxCa), minimizing
morbidity and mortality. Most large US reports on cytology and human papillomavirus (HPV) …

OBJECTIVE: To compare test performance characteristics of conventional Pap tests and
liquid-based cervical cytology samples. DATA SOURCES: Eligible studies, published …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

Objective This study evaluates the feasibility and performance of care HPV, a novel human
papillomavirus (HPV) DNA test, when used for screening women for cervical cancer in low …

Objective To evaluate human papillomavirus (HPV) testing in combination with cytology in
the follow up of treated women. Design A prospective study. Setting Three UK centres …

Objectives: We measured the accuracy of p16INK4a-Ki67 (CINtec PLUS, Roche, Mannheim,
Germany), and E6/E7mRNA (types 16/18/31/33/45 NucliSENS easyQ, bioMérieux, Boxtel …

Background A new test (careHPV; QIAGEN, Gaithersburg, MD, USA) has been developed to
detect 14 high-risk types of carcinogenic human papillomavirus (HPV) in about 2· 5 h, to …

Abstract Background: Human papillomavirus (HPV)–based screening needs triage. In most
randomized controlled trials (RCTs) on HPV testing with cytological triage, cytology …